Patent · US Active

Nucleoside phosphoramidates

US8957045B2 · kind B2 · utility

23Cited by
220References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateFeb 25, 2013
Grant dateFeb 17, 2015
Priority date—
Expiry dateFeb 25, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

A nucleoside compound having activity against hepatitis C virus is disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.